메뉴 건너뛰기




Volumn 31, Issue 7, 2008, Pages 938-944

The effect of coenzyme Q10 on the pharmacokinetic parameters of theophylline

Author keywords

Coenzyme Q10; Cytochrome P450; Pharmacokinetic parameters; Protein binding; Theophylline

Indexed keywords

ANTIOXIDANT; BRONCHODILATING AGENT; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; DRUG DERIVATIVE; THEOPHYLLINE; UBIDECARENONE; UBIQUINONE;

EID: 49749146321     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-001-1250-1     Document Type: Article
Times cited : (7)

References (36)
  • 1
    • 0003700389 scopus 로고    scopus 로고
    • AHFS. Board of the AHFS Bethesda
    • AHFS (American Society of Health-System Pharmacists), AHFS drug information. Board of the AHFS, Bethesda (2007).
    • (2007) AHFS Drug Information
  • 2
    • 0023276097 scopus 로고
    • Alpha-naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin- induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression
    • Blank, J., Tucker, A., Sweatlock, J., Gasiewicz, T., and Luster, M., Alpha-naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression. Mol. Pharmacol., 32, 169-172 (1987).
    • (1987) Mol. Pharmacol. , vol.32 , pp. 169-172
    • Blank, J.1    Tucker, A.2    Sweatlock, J.3    Gasiewicz, T.4    Luster, M.5
  • 4
    • 33749985009 scopus 로고    scopus 로고
    • New pharmacologic horizons in the treatment of Parkinson disease
    • 7Suppl2
    • Bonuccelli, U. and Del Dotto, P., New pharmacologic horizons in the treatment of Parkinson disease. Neurology, 67(7 Suppl 2), S30-S38 (2006).
    • (2006) Neurology , vol.67
    • Bonuccelli, U.1    Del Dotto, P.2
  • 6
    • 33847064247 scopus 로고    scopus 로고
    • Use of dietary supplements among United States adults with coronary artery disease and atherosclerotic risks
    • Buettner, C., Phillips, R., Davis, R., Gardiner, P., and Mittleman, M., Use of dietary supplements among United States adults with coronary artery disease and atherosclerotic risks. Am. J. Cardiol., 99, 661-666 (2007).
    • (2007) Am. J. Cardiol. , vol.99 , pp. 661-666
    • Buettner, C.1    Phillips, R.2    Davis, R.3    Gardiner, P.4    Mittleman, M.5
  • 7
    • 19544371393 scopus 로고    scopus 로고
    • Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity. Integr
    • Conklin, K., Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity. Integr. Cancer Ther., 4, 110-130 (2005).
    • (2005) Cancer Ther. , vol.4 , pp. 110-130
    • Conklin, K.1
  • 8
    • 0035667921 scopus 로고    scopus 로고
    • Biochemical functions of coenzyme Q10
    • Crane, F., Biochemical functions of coenzyme Q10. J. Am. Coll. Nutr., 20, 591-598 (2001).
    • (2001) J. Am. Coll. Nutr. , vol.20 , pp. 591-598
    • Crane, F.1
  • 10
    • 33749565579 scopus 로고    scopus 로고
    • Factors associated with dietary supplement use among prescription medication users
    • Gardiner, P., Graham, R., Legedza, A., Eisenberg, D., and Phillips, S., Factors associated with dietary supplement use among prescription medication users. Arch. Intern. Med., 166, 1968-1974 (2006).
    • (2006) Arch. Intern. Med. , vol.166 , pp. 1968-1974
    • Gardiner, P.1    Graham, R.2    Legedza, A.3    Eisenberg, D.4    Phillips, S.5
  • 11
    • 38149135135 scopus 로고    scopus 로고
    • Herbal and dietary supplement-drug interactions in patients with chronic illnesses
    • Gardiner, P., Phillips, R., and Shaughnessy, A., Herbal and dietary supplement-drug interactions in patients with chronic illnesses. Am. Fam. Physician, 77, 73-78 (2008).
    • (2008) Am. Fam. Physician , vol.77 , pp. 73-78
    • Gardiner, P.1    Phillips, R.2    Shaughnessy, A.3
  • 12
    • 0025195880 scopus 로고
    • Co-enzyme Q10: A new drug for cardiovascular disease
    • Greenberg, S. and Frishman, W. Co-enzyme Q10: a new drug for cardiovascular disease. J. Clin. Pharmacol., 30, 596-608 (1990).
    • (1990) J. Clin. Pharmacol. , vol.30 , pp. 596-608
    • Greenberg, S.1    Frishman, W.2
  • 13
    • 0036827017 scopus 로고    scopus 로고
    • Coenzyme Q10 improves blood pressure and glycaemic control: A controlled trial in subjects with type 2 diabetes
    • Hodgson, J., Watts, G., Playford, D., Burke, V., and Croft, K., Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes. Eur. J. Clin. Nutr., 56, 1137-1142 (2002).
    • (2002) Eur. J. Clin. Nutr. , vol.56 , pp. 1137-1142
    • Hodgson, J.1    Watts, G.2    Playford, D.3    Burke, V.4    Croft, K.5
  • 14
    • 33845938278 scopus 로고    scopus 로고
    • Calorie restriction up-regulates the plasma membrane redox system in brain cells and suppresses oxidative stress during aging
    • Hyun, D., Emerson, S., Jo, D., Mattson, M., and de Cabo, R., Calorie restriction up-regulates the plasma membrane redox system in brain cells and suppresses oxidative stress during aging. Proc. Natl. Acad. Sci. USA, 103, 19908-19912 (2006).
    • (2006) Proc. Natl. Acad. Sci. USA , vol.103 , pp. 19908-19912
    • Hyun, D.1    Emerson, S.2    Jo, D.3    Mattson, M.4    De Cabo, R.5
  • 15
    • 38449083250 scopus 로고    scopus 로고
    • Orthomolecular medicine: The therapeutic use of dietary supplements for anti-aging
    • Janson, M., Orthomolecular medicine: the therapeutic use of dietary supplements for anti-aging. Clin. Interv. Aging, 1, 261-265 (2006).
    • (2006) Clin. Interv. Aging , vol.1 , pp. 261-265
    • Janson, M.1
  • 16
    • 0031015345 scopus 로고    scopus 로고
    • Human P450 metabolism of warfarin
    • Kaminsky, L. and Zhang, Z., Human P450 metabolism of warfarin. Pharmacol. Ther., 73, 67-74 (1997).
    • (1997) Pharmacol. Ther. , vol.73 , pp. 67-74
    • Kaminsky, L.1    Zhang, Z.2
  • 18
    • 0028226079 scopus 로고
    • Serum ubiquinone concentrations after short-and long-term treatment with HMG-CoA reductase inhibitors
    • Laaksonen, R., Ojala, J., Tikkanen, M., and Himberg, J., Serum ubiquinone concentrations after short-and long-term treatment with HMG-CoA reductase inhibitors. Eur. J. Clin. Pharmacol., 46, 313-317 (1994).
    • (1994) Eur. J. Clin. Pharmacol. , vol.46 , pp. 313-317
    • Laaksonen, R.1    Ojala, J.2    Tikkanen, M.3    Himberg, J.4
  • 19
    • 0032565599 scopus 로고    scopus 로고
    • Interaction between warfarin and coenzyme Q10
    • Landbo, C. and Almdal, T., Interaction between warfarin and coenzyme Q10. Ugeskr. Laeger., 160, 3226-3227 (1998).
    • (1998) Ugeskr. Laeger. , vol.160 , pp. 3226-3227
    • Landbo, C.1    Almdal, T.2
  • 23
    • 33745600868 scopus 로고    scopus 로고
    • Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective
    • Ratnam, D., Ankola, D., Bhardwaj, V., Sahana, D., and Kumar, M., Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. J. Control. Release, 113, 189-207 (2006).
    • (2006) J. Control. Release , vol.113 , pp. 189-207
    • Ratnam, D.1    Ankola, D.2    Bhardwaj, V.3    Sahana, D.4    Kumar, M.5
  • 24
    • 16544375906 scopus 로고    scopus 로고
    • Efficacy of coenzyme Q10 for improved tolerability of cancer treatments: A systematic review
    • Roffe, L., Schmidt, K., and Ernst, E., Efficacy of coenzyme Q10 for improved tolerability of cancer treatments: a systematic review. J. Clin. Oncol., 22, 4418-4424 (2004).
    • (2004) J. Clin. Oncol. , vol.22 , pp. 4418-4424
    • Roffe, L.1    Schmidt, K.2    Ernst, E.3
  • 25
    • 0028725070 scopus 로고
    • Exogenous CoQ10 preserves plasma ubiquinone levels in patients treated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
    • Sassi, S., Genova, M., and Lenaz, G., Exogenous CoQ10 preserves plasma ubiquinone levels in patients treated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Int. J. Clin. Lab. Res., 24, 171-176 (1994).
    • (1994) Int. J. Clin. Lab. Res. , vol.24 , pp. 171-176
    • Sassi, S.1    Genova, M.2    Lenaz, G.3
  • 26
    • 33746048422 scopus 로고    scopus 로고
    • Clinical trials of coenzyme Q10 in neurological disorders
    • Shults, C. and Haas, R., Clinical trials of coenzyme Q10 in neurological disorders. Biofactors, 25, 117-126 (2005).
    • (2005) Biofactors , vol.25 , pp. 117-126
    • Shults, C.1    Haas, R.2
  • 27
    • 3042717908 scopus 로고    scopus 로고
    • Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease
    • Shults, C., Flint Beal, M., Song, D., and Fontaine, D., Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease. Exp. Neurol., 188, 491-494 (2004).
    • (2004) Exp. Neurol. , vol.188 , pp. 491-494
    • Shults, C.1    Flint Beal, M.2    Song, D.3    Fontaine, D.4
  • 28
    • 34547166634 scopus 로고    scopus 로고
    • Coenzyme Q10 supplementation and heart failure
    • 6Pt1
    • Singh, U., Devaraj, S., and Jialal, I., Coenzyme Q10 supplementation and heart failure. Nutr. Rev., 65(6 Pt 1), 286-293 (2007).
    • (2007) Nutr. Rev. , vol.65 , pp. 286-293
    • Singh, U.1    Devaraj, S.2    Jialal, I.3
  • 31
    • 35348982778 scopus 로고    scopus 로고
    • Herb-drug interactions: Effect of Ginkgo biloba extract on the pharmacokinetics of theophylline in rats
    • Tang, J., Sun, J., Zhang, Y., Li, L., Cui, F., and He, Z., Herb-drug interactions: Effect of Ginkgo biloba extract on the pharmacokinetics of theophylline in rats. Food Chem. Toxicol., 45, 2441-2445 (2007).
    • (2007) Food Chem. Toxicol. , vol.45 , pp. 2441-2445
    • Tang, J.1    Sun, J.2    Zhang, Y.3    Li, L.4    Cui, F.5    He, Z.6
  • 32
    • 0030094638 scopus 로고    scopus 로고
    • Theophylline metabolism in human liver microsomes: Inhibition studies
    • Tjia, J., Colbert, J., and Back, D., Theophylline metabolism in human liver microsomes: inhibition studies. J. Pharmacol. Exp. Ther., 276, 912-917 (1996).
    • (1996) J. Pharmacol. Exp. Ther. , vol.276 , pp. 912-917
    • Tjia, J.1    Colbert, J.2    Back, D.3
  • 33
    • 0034743523 scopus 로고    scopus 로고
    • Role of coenzyme Q10 in chronic heart failure, angina, and hypertension
    • Tran, M., Mitchell, T., Kennedy, D., and Giles, J., Role of coenzyme Q10 in chronic heart failure, angina, and hypertension. Pharmacotherapy, 21, 797-806 (2001).
    • (2001) Pharmacotherapy , vol.21 , pp. 797-806
    • Tran, M.1    Mitchell, T.2    Kennedy, D.3    Giles, J.4
  • 34
    • 14144252741 scopus 로고    scopus 로고
    • Acute administration of red yeast rice (Monascus purpureus) depletes tissue coenzyme Q(10) levels in ICR mice
    • Yang, H., Lin, S., Huang, S., and Chou, H., Acute administration of red yeast rice (Monascus purpureus) depletes tissue coenzyme Q(10) levels in ICR mice. Br. J. Nutr., 93, 131-135 (2005).
    • (2005) Br. J. Nutr. , vol.93 , pp. 131-135
    • Yang, H.1    Lin, S.2    Huang, S.3    Chou, H.4
  • 36
    • 15444364956 scopus 로고    scopus 로고
    • Effect of coenzyme Q10 on warfarin hydroxylation in rat and human liver microsomes
    • Zhou, Q., Zhou, S., and Chan, E., Effect of coenzyme Q10 on warfarin hydroxylation in rat and human liver microsomes. Curr. Drug Metab., 6, 67-81 (2005).
    • (2005) Curr. Drug Metab. , vol.6 , pp. 67-81
    • Zhou, Q.1    Zhou, S.2    Chan, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.